Arthrosamid 2.5% PAAG – The Human Equivalent

Arthrosamid is the 2.5% polyacrylamide hydrogel developed as a long-acting intra-articular injection for the treatment of osteoarthritis in humans. Arthrosamid® is a new type of treatment for knee osteoarthritis that…

Use of Arthramid Vet in Canine Intra-articular injections

Nupsala Learning Resources in the UK recently published a webinar on Canine Intra-articular Injection. Dr Karen Cook BA VetMB BSc (Hons) MRCVS presents an informative webinar on the injection technique…

Treatment of intercarpal (knee) joint lameness in TB racehorses

Use Of a 2.5% Cross-Linked Polyacrylamide Hydrogel In The Management Of Joint Lameness In a Population Of Flat Racing Thoroughbreds: A Pilot Sudy Published in JEVS; https://www.sciencedirect.com/science/article/pii/S0737080618307615 Abstract Osteoarthritis is one…

Clinical Safety of Arthramid Vet 2.5% PAAG Hydrogel

Both in vitro and in vivo studies have taken place, designed to generate data on the safety of Arthramid Vet and to support regulatory submissions for market authorisation. Most current…

Arthramid Vet 2.5% PAAG Hydrogel- Efficacy Study Abstract

Intra-articular administration of a 2.5% polyacrylamide hydrogel (PAAG- Arthramid Vet) is shown to reduce or abolish lameness in distal interphalangeal (coffin) and metacarpo/ metatarso- phalangeal (fetlock) joints in horses undertaking…

Arthramid Vet 2.5% PAAG – Mechanism Of Action

Osteoarthritis (OA) describes inflammation of a joint and occurs after single or repetitive episodes of trauma. The term incorporates synovitis, capsulitis, sprain, intra-articular fractures, meniscal tears, and OA. These pathological…

Interested in talking to us and learning more?

Schedule a time with one of our experts
BOOK NOW